학술논문
Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial
Document Type
Article
Author
Mateo, Joaquin ; Porta, Nuria ; Bianchini, Diletta; McGovern, Ursula; Elliott, Tony; Jones, Robert; Syndikus, Isabel; Ralph, Christy; Jain, Suneil; Varughese, Mohini; Parikh, Omi; Crabb, Simon; Robinson, Angus; McLaren, Duncan; Birtle, Alison; Tanguay, Jacob; Miranda, Susana; Figueiredo, Ines; Seed, George; Bertan, Claudia; Flohr, Penny; Ebbs, Berni; Rescigno, Pasquale; Fowler, Gemma; Ferreira, Ana; Riisnaes, Ruth; Pereira, Rita; Curcean, Andra; Chandler, Robert; Clarke, Matthew; Gurel, Bora; Crespo, Mateus; Nava Rodrigues, Daniel; Sandhu, Shahneen; Espinasse, Aude; Chatfield, Peter; Tunariu, Nina; Yuan, Wei; Hall, Emma; Carreira, Suzanne; de Bono, Johann S
Source
In The Lancet Oncology January 2020 21(1):162-174
Subject
Language
ISSN
1470-2045